Magenta Therapeutics, Inc. announced the appointment of Caren Deardorf as the company’s first chief commercial officer. As chief commercial officer, Ms. Deardorf will serve as a member of the company’s Executive Team and will be responsible for establishing the strategy, direction and execution of Magenta’s global commercial capabilities. Ms. Deardorf has more than 25 years of international biotechnology leadership experience across a range of therapeutic areas. She comes to the company from Ohana Biosciences.